Frontlight ResearchEarly access
Not yet taking people in United StatesPhase 2
THiamine for Recovery In Vulnerable Early-life Infections
Key facts
- Who runs it
- Milton S. Hershey Medical Center
- Where
- Boston and Hershey, United StatesSee the 2 sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 240 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 30 Nov 2031
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- thiamine hydrochloride 100 mg
- Placebo
- Record updated
- 9 October 2026
Who can take part
- Age
- Up to 12 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- ≤12 months old
- Clinical concern for bacteremia or meningitis (fever or hypothermia and lethargy; fever or hypothermia and poor feeding; fever or hypothermia and seizure, bulging fontanelle or nuchal rigidity)
- Legal guardian has provided informed consent
- No known neurologic or developmental comorbidity (e.g. trisomy 21, congenital structural brain abnormality)
- Weight ≥ 2kg
Who cannot take part
- Prior episode of bacteremia or meningitis
- Already receiving thiamine as standard-of-care
- Known neurologic or developmental comorbidity including genetic disorders
- Weight < 2 kg
Where in United States
- Boston Children's HospitalBoston, United StatesContact: Sarah U. Morton, MD, PhDNot yet recruiting
- Penn State Health Milton S. Hershey Medical CenterHershey, United StatesContact: Brennen Harding, MSNot yet recruiting
About the trial
What the trial wants to find out
To determine if the addition of thiamine to standard-of-care treatment will improve neurodevelopmental outcomes for infants with meningitis or bacteremia
The 2 groups in the trial
- ThiamineTreatment being tested
Participant will receive IV thiamine in addition to standard of care treatment
Treatment: thiamine hydrochloride 100 mg
- PlaceboPlacebo, for comparison
Participant will receive placebo (IV saline solution) in addition to standard-of-care treatment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 9 October 2026